Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Chloroadenosine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114249785A details a hydrazine-free synthesis of regadenoson intermediates using cesium carbonate catalysis, offering safer manufacturing and high purity for pharmaceutical supply chains.
Patent CN112159447B details a novel DMAP-catalyzed route for 2-chloroadenosine, offering superior purity and yield while eliminating heavy metal contamination for scalable API production.